sabinene has been researched along with Dyslipidemias in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Alisente, S; Baila-Rueda, L; Bea, AM; Cenarro, A; Civeira, F; Giné-González, J; Jarauta, E; Lamiquiz-Moneo, I; Marco-Benedí, V; Mateo-Gallego, R; Pérez-Calahorra, S | 1 |
| Amodio, N; Bedossa, P; Bosco, F; Caffrey, R; Carresi, C; Ehrlich, J; Gliozzi, M; Juli, G; Macrì, R; Maiuolo, J; Marioneaux, J; Mollace, R; Mollace, V; Muscoli, C; Musolino, V; Nucera, S; Palma, E; Ruga, S; Salvemini, D; Sanyal, AJ; Scarano, F; Scicchitano, M; Tassone, P; Walker, R; Zito, MC | 1 |
| Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J | 1 |
| Castro, MA; Crespo, R; Galle, ME; Gavernet, L; Llanos, MA; Rodenak-Kladniew, BE | 1 |
| Cai, Y; Rao, J; Shen, T; Shi, R; Xing, G; Zhang, S | 1 |
| Calvani, R; Di Giorgio, A; Giupponi, B; Landi, F; Martone, AM; Marzetti, E; Nesci, A; Salini, S; Santoliquido, A; Santoro, L; Zazzara, B | 1 |
| Fan, S; Gu, M; Guan, Y; Huang, C; Jing, L; Lu, X; Zhang, Y; Zhou, Z | 1 |
| Al-Rasadi, K; Giglio, RV; Ivanova, E; Katsiki, N; Li Volti, G; Mikhailidis, DP; Montalto, G; Nikolic, D; Orekhov, AN; Patti, AM; Rizzo, M | 1 |
| Babish, JG; Brabazon, H; Dahlberg, CJ; Gao, W; Kaadige, MR; Keller, WJ; Kou, X; Lamb, J; Ou, JJ; Pacioretty, LM; Soudah, HC; Tripp, ML; Zhang, Z | 1 |
| Ahn, J; Ha, TY; Hur, J; Hwang, JT; Jang, YJ; Jeon, EJ; Jung, CH; Kim, M; Kim, MJ; Kim, YJ; Lee, DH; Lee, JS; Seo, DH; Sung, MJ | 1 |
| Assini, JM; Huff, MW; Mulvihill, EE | 1 |
4 review(s) available for sabinene and Dyslipidemias
| Article | Year |
|---|---|
Effect of bergamot on lipid profile in humans: A systematic review.
Topics: Cholesterol, HDL; Citrus; Dyslipidemias; Humans; Lipids; Plant Extracts; Triglycerides | 2020 |
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors | 2020 |
The effect of bergamot on dyslipidemia.
Topics: Animals; Citrus; Dyslipidemias; Flavonoids; Humans; Hypolipidemic Agents; Plant Extracts | 2016 |
Citrus flavonoids and lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy | 2013 |
3 trial(s) available for sabinene and Dyslipidemias
| Article | Year |
|---|---|
Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Citrus; Dietary Supplements; Double-Blind Method; Dyslipidemias; Female; Humans; Lipid Metabolism; Male; Middle Aged; Plant Extracts; Triglycerides; Waist Circumference | 2017 |
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial.
Topics: Adult; Aged; Biological Products; Chromium; Citrus; Dietary Supplements; Dyslipidemias; Endothelial Cells; Fatty Acids, Omega-3; Fatty Alcohols; Female; Humans; Lipid Metabolism; Lipids; Male; Middle Aged; Ubiquinone; Xanthophylls | 2019 |
Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including Citrus bergamia, in subjects with moderate cardiometabolic risk factors.
Topics: Adult; Aged; Antioxidants; Citrus; Drug Compounding; Drug Synergism; Dyslipidemias; Female; Humans; Male; Metabolic Diseases; Middle Aged; Phytochemicals; Pilot Projects; Plant Extracts; Risk Factors | 2016 |
4 other study(ies) available for sabinene and Dyslipidemias
| Article | Year |
|---|---|
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease.
Topics: Animals; Citrus; Diet, Western; Disease Models, Animal; Dyslipidemias; Gene Expression; Humans; Inflammation; MAP Kinase Kinase 4; Mice; Non-alcoholic Fatty Liver Disease; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Polyphenols | 2020 |
Citrus reticulata peel oil as an antiatherogenic agent: Hypolipogenic effect in hepatic cells, lipid storage decrease in foam cells, and prevention of LDL oxidation.
Topics: Animals; Antioxidants; Atherosclerosis; CD36 Antigens; Cholesterol; Citrus; Dyslipidemias; Foam Cells; Fruit; Hep G2 Cells; Hepatocytes; Humans; Hypolipidemic Agents; Intramolecular Transferases; Lipid Peroxidation; Lipoproteins, LDL; Mice; Molecular Docking Simulation; Plant Oils; RAW 264.7 Cells | 2020 |
Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Body Weight; Cell Differentiation; Cell Size; Citrus; Cyclohexenes; Diet, High-Fat; Dietary Supplements; Dyslipidemias; Female; Gene Expression Regulation; Glucose; Hyperglycemia; Limonene; Lipids; Liver; Liver X Receptors; Mice; Mice, Inbred C57BL; Obesity; Orphan Nuclear Receptors; PPAR alpha; Signal Transduction; Terpenes | 2013 |
Effects of yuja peel extract and its flavanones on osteopenia in ovariectomized rats and osteoblast differentiation.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Bone Density; Bone Diseases, Metabolic; Bone Morphogenetic Protein 2; Cell Differentiation; Citrus; Core Binding Factor Alpha 1 Subunit; Dyslipidemias; Female; Flavanones; Mice; Osteoblasts; Osteocalcin; Osteogenesis; Ovariectomy; Plant Extracts; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Smad Proteins, Receptor-Regulated | 2016 |